Physician
Monument Pathologists INC
Monument Pathologists INC was paid $2.83M by Medicaid between Jan 2018 and Dec 2024, across 145 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 50% of everything it billed.
33Billing provider infoMONUMENT PATHOLOGISTS INC
RICHMOND, VA 23226
RICHMOND, VA 23226
33aNPI1700878238assigned 08/19/2005
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$2.83M
24GClaims1,413,221
24DCodes billed145
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Virginia
Rank by total paid#2 of 63
Median peer was paid$6K
This provider vs. median457×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48,643 | $124K | |
| 2019 | 138,946 | $349K | |
| 2020 | 145,240 | $289K | |
| 2021 | 203,980 | $453K | |
| 2022 | 277,998 | $493K | |
| 2023 | 302,942 | $614K | |
| 2024incomplete | 295,472 | $513K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 50% | 30,297 | 25,093 | $1.41M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 9.5% | 2,914 | 2,652 | $268K |
| 88307 | 6.2% | 2,614 | 2,396 | $175K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.8% | 21,433 | 19,200 | $164K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.9% | 14,900 | 13,710 | $138K |
| 80053 | Comprehensive metabolic panel | 2.7% | 149,515 | 103,159 | $76K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.4% | 12,796 | 12,075 | $67K |
| 82962 | 2.1% | 90,933 | 28,244 | $60K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 186,268 | 116,335 | $43K |
| 84484 | 1.1% | 46,919 | 37,826 | $32K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.1% | 67,735 | 29,998 | $32K |
| 83735 | 1.0% | 61,548 | 29,109 | $29K |
133 more codes
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.0% | 12,490 | $29K |
| 88342 | <1% | 1,293 | $27K | |
| 81001 | <1% | 81,197 | $16K | |
| 83605 | <1% | 21,024 | $16K | |
| 84145 | <1% | 10,162 | $14K | |
| 87040 | <1% | 16,606 | $14K | |
| 85027 | <1% | 44,301 | $13K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 10,123 | $11K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 9,824 | $11K |
| 88304 | <1% | 1,242 | $11K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 15,172 | $11K |
| 83690 | <1% | 36,004 | $11K | |
| 85060 | <1% | 782 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 20,281 | $8K |
| 83880 | <1% | 16,415 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,886 | $7K |
| 84100 | <1% | 26,353 | $7K | |
| 80050 | General health panel | <1% | 1,003 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 17,690 | $6K |
| 85610 | <1% | 20,691 | $6K | |
| 85730 | <1% | 10,756 | $6K | |
| 86901 | <1% | 22,197 | $6K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 16,697 | $5K |
| 87077 | <1% | 9,294 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 11,604 | $5K |
| 87070 | <1% | 20,523 | $5K | |
| 86923 | <1% | 2,059 | $4K | |
| 87186 | <1% | 8,710 | $4K | |
| 82077 | <1% | 10,047 | $3K | |
| 87210 | <1% | 7,087 | $3K | |
| 82803 | <1% | 4,748 | $3K | |
| 80202 | <1% | 3,691 | $3K | |
| 82728 | <1% | 3,058 | $3K | |
| 80069 | <1% | 5,099 | $2K | |
| 85379 | <1% | 10,625 | $2K | |
| 86140 | <1% | 10,096 | $2K | |
| 82247 | <1% | 9,417 | $2K | |
| 82550 | <1% | 8,034 | $2K | |
| 86900 | <1% | 22,192 | $2K | |
| 80061 | Lipid panel | <1% | 4,928 | $2K |
| 86850 | <1% | 16,213 | $2K | |
| 87205 | <1% | 5,677 | $2K | |
| 80143 | <1% | 3,303 | $1K | |
| 82553 | <1% | 791 | $1K | |
| 87147 | <1% | 3,937 | $1K | |
| 82140 | <1% | 1,532 | $1K | |
| 82607 | <1% | 2,005 | $1K | |
| 87506 | <1% | 52 | $1K | |
| 80076 | <1% | 3,066 | $1K | |
| 80179 | <1% | 3,085 | $1K | |
| 81025 | <1% | 42,772 | $1K | |
| 83540 | <1% | 3,018 | $1K | |
| 87581 | <1% | 97 | $1K | |
| 87486 | <1% | 97 | $1K | |
| 88189 | <1% | 31 | $1K | |
| 83550 | <1% | 2,214 | $1K | |
| 85652 | <1% | 4,088 | $976.29 | |
| 87807 | <1% | 3,109 | $963.65 | |
| 84702 | <1% | 4,278 | $897.10 | |
| 84703 | <1% | 4,599 | $799.46 | |
| 83615 | <1% | 2,830 | $727.95 | |
| 82746 | <1% | 1,379 | $721.22 | |
| 82330 | <1% | 2,075 | $628.09 | |
| 82570 | <1% | 2,883 | $588.77 | |
| 85018 | <1% | 6,123 | $581.99 | |
| 84439 | <1% | 1,583 | $481.81 | |
| 80047 | <1% | 1,141 | $468.56 | |
| 87641 | <1% | 844 | $461.42 | |
| 86880 | <1% | 2,392 | $456.76 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 97 | $435.34 |
| 85007 | <1% | 1,772 | $380.87 | |
| 88341 | <1% | 14 | $332.30 | |
| 85520 | <1% | 692 | $299.03 | |
| 81003 | <1% | 2,647 | $278.59 | |
| 84132 | <1% | 2,391 | $273.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 97 | $260.00 |
| 88300 | <1% | 60 | $250.58 | |
| 85014 | <1% | 2,764 | $215.08 | |
| 84295 | <1% | 1,482 | $201.39 | |
| 87808 | <1% | 565 | $186.80 | |
| 82947 | <1% | 1,775 | $186.20 | |
| 85384 | <1% | 1,113 | $175.64 | |
| 86921 | <1% | 16 | $158.03 | |
| 85045 | <1% | 560 | $153.60 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 408 | $129.24 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 31 | $126.84 |
| 87088 | <1% | 763 | $120.87 | |
| 82272 | <1% | 560 | $115.54 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 126 | $98.92 |
| 87340 | <1% | 189 | $95.57 | |
| 84156 | <1% | 1,452 | $87.98 | |
| 87634 | <1% | 1,376 | $70.20 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 422 | $70.18 |
| 86922 | <1% | 16 | $63.21 | |
| 80177 | <1% | 45 | $56.28 | |
| 84550 | <1% | 262 | $50.10 | |
| 80074 | <1% | 25 | $50.01 | |
| 86920 | <1% | 61 | $44.10 | |
| 87899 | <1% | 12 | $42.84 | |
| 82565 | <1% | 227 | $35.85 | |
| 86592 | <1% | 877 | $33.29 | |
| 82248 | <1% | 417 | $30.62 | |
| 83970 | <1% | 88 | $30.39 | |
| 87449 | <1% | 127 | $28.64 | |
| 84300 | <1% | 156 | $28.24 | |
| 84030 | <1% | 1,095 | $27.64 | |
| 80164 | <1% | 33 | $23.75 | |
| 82378 | <1% | 34 | $18.44 | |
| 86706 | <1% | 98 | $15.35 | |
| 89050 | <1% | 237 | $15.03 | |
| 87427 | <1% | 12 | $14.28 | |
| 83010 | <1% | 35 | $13.61 | |
| 86141 | <1% | 13 | $11.76 | |
| 87075 | <1% | 43 | $10.53 | |
| 87046 | <1% | 12 | $6.24 | |
| 86704 | <1% | 57 | $4.87 | |
| 84157 | <1% | 29 | $4.00 | |
| 87045 | <1% | 12 | $3.75 | |
| 86738 | <1% | 16 | $2.64 | |
| 87150 | 0% | 80 | $0.00 | |
| 83655 | 0% | 161 | $0.00 | |
| 81002 | 0% | 99 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 195 | $0.00 |
| 85347 | 0% | 20 | $0.00 | |
| 86780 | 0% | 419 | $0.00 | |
| 86803 | 0% | 25 | $0.00 | |
| 86304 | 0% | 12 | $0.00 | |
| 87154 | 0% | 198 | $0.00 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 0% | 20 | $0.00 |
| 82657 | 0% | 12 | $0.00 | |
| 87255 | 0% | 12 | $0.00 | |
| 82784 | 0% | 14 | $0.00 | |
| 84478 | 0% | 56 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILSON, JACK (DIRECTOR)